Clinical Trials Directory

Trials / Sponsors / SIGA Technologies

SIGA Technologies

Industry · 9 registered clinical trials.

StatusTrialPhaseStarted
CompletedDrug-drug Interaction Study of TPOXX When Co-administered With Phosphate Binders
Smallpox
Phase 42022-06-08
Active Not RecruitingStudy to Assess the Safety and Immunogenicity of TPOXX® When Administered Orally for 28 Days With JYNNEOS
Smallpox
Phase 22022-04-05
CompletedSafety, Tolerability and Pharmacokinetics of TPOXX When Administered Orally for 28 Days
Smallpox
Phase 32022-03-29
WithdrawnA Phase 4, Observational Field Study to Evaluate TPOXX in Patients With Smallpox
Smallpox
—2020-01-01
CompletedSafety, Tolerability and PK of TPOXX in Adults Weighing More Than 120 KG
Smallpox
Phase 42019-07-19
CompletedA Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound Tecovirima
Smallpox
Phase 32015-06-19
CompletedSafety, Tolerability, Pharmacokinetics (PK) of the Anti-Orthopox Drug, ST-246
Orthopoxviral Disease
Phase 22009-06-01
CompletedPhase I Trial of an Investigational Small Pox Medication
Orthopoxviral Disease, Smallpox, Monkey Pox
Phase 12008-08-01
CompletedPhase I, Escalating, Multiple-Dose, ST-246 Safety, Tolerability and Pharmacokinetics 21-Day Trial in Healthy V
Healthy
Phase 12007-02-01